Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan:108:115-122.
doi: 10.1016/j.jsat.2019.08.006. Epub 2019 Oct 24.

Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results

Larissa J Mooney  1 , Jonathan Valdez  2 , Sarah J Cousins  2 , Caroline Yoo  2 , Yuhui Zhu  2 , Yih-Ing Hser  2
Affiliations

Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results

Larissa J Mooney et al. J Subst Abuse Treat. 2020 Jan.

Abstract

Background and aims: As treatment for opioid use disorder (OUD) expands within general healthcare settings such as primary care, mechanisms to facilitate decision-making processes are increasingly necessary. Decision aids have the capacity to bolster existing resources in diverse treatment settings by increasing knowledge of treatment options and facilitating shared decision making. The aim of this study is to develop and test a patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD) that assists individuals with OUD in making informed decisions about treatment at the time of initial clinical visit. Use of the PtDA-MOUD will be further tested in diverse treatment settings within the California Hub and Spoke System developed under the SAMHSA State Targeted Response to the Opioid Crisis grants.

Methods: The PtDA-MOUD was iteratively developed with input from a scientific expert panel and both patient and provider focus groups, incorporating International Patient Decision Aid Standards. Thirty-six patients with OUD entering treatment pilot tested the PtDA and completed assessments, and results from clinical records were compared with matched controls who did not receive the PtDA. A clinical profile based on assessment data was created for use within the clinical visit.

Results: The developed decision aid provides information on MOUD and captures patient characteristics relevant to medication treatment decisions. Feedback indicated that the PtDA-MOUD was feasible to implement and useful. Though the small sample size limited the ability to detect significant differences (p > .05), a greater number of individuals who reviewed the PtDA (37%) were inducted on MOUD than controls (11%) and received MOUD for more days (M = 14.0, SD = 24.7) than controls (M = 8.4; SD = 22.5). Moreover, the difference in means for days receiving MOUD had an approximately medium effect size (r = 0.25).

Conclusions: Patient perceptions of the decision aid were favorable and it showed promise as a tool in the OUD treatment process. Pilot testing results suggested preliminary positive effects on MOUD initiation. Future phases of this study will further investigate the usefulness of this tool. ClinicalTrials.govIdentifier:NCT03394261.

Keywords: Decision aid; Development; Evaluation; Medication treatment; Opioid use disorder.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Design for developing and testing of PtDA-MOUD
Figure 2.
Figure 2.
Distribution of the number of days in MOUD for pilot and control groups. Jittered circle (o) indicates participants. Star (*) indicates outliers.
See this image and copyright information in PMC

References

    1. Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, … & Cajina A (2011). HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. Journal of Acquired Immune Deficiency Syndromes (1999), 56(Suppl 1), S22. - PMC - PubMed
    1. Brener L, Resnick I, Ellard J, Treloar C, & Bryant J (2009). Exploring the role of consumer participation in drug treatment. Drug and Alcohol Dependence, 105(1–2), 172–175. - PubMed
    1. Brooklyn JR, & Sigmon SC (2017). Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact. Journal of Addiction Medicine, 11(4), 286. - PMC - PubMed
    1. Charles C, & Gafni A (2014). The vexing problem of defining the meaning, role and measurement of values in treatment decision-making. Journal of Comparative Effectiveness Research, 3(2), 197–209. - PubMed
    1. Centers for Disease Control and Prevention, National Center for Health Statistics (2018). Drug overdose deaths in the United States, 1999–2017. Retrieved from: https://www.cdc.gov/nchs/products/databriefs/db329.htm - PubMed

Publication types

Associated data